Randomized Placebo-Controlled Trial to Determine the Biological Signature of Cannabidiol as a Treatment for Social Anxiety Disorder

Brief description of study

The purpose of this research study is to determine whether cannabidiol (CBD), a non-psychoactive part of cannabis, is an effective treatment for social anxiety disorder (SAD), and to better understand how CBD might improve SAD symptoms. After medical and psychiatric evaluations are completed, eligible participants are randomly assigned (that is, by chance) to one of two treatments lasting approximately 3 weeks: CBD or placebo. The study will last about 1-2 months and full participation includes 6 study visits as well as fMRI neuroimaging scans, a stress task, and blood tests. Eligible participants receive compensation for time completing study assessments.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.